Shares of Consort Medical plc (NASDAQ:CSRMY) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation. Consort Medical plc’s rating score has improved by 66.7% in the last three months as a result of a number of analysts’ ratings changes.

Zacks has also given Consort Medical plc an industry rank of 167 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research cut Consort Medical plc from a “hold” rating to a “sell” rating in a research note on Tuesday, May 2nd.

Consort Medical plc (NASDAQ:CSRMY) opened at 15.00 on Tuesday. The firm has a 50-day moving average price of $14.19 and a 200-day moving average price of $13.46. Consort Medical plc has a 52 week low of $12.90 and a 52 week high of $15.00. The company has a market cap of $733.70 million and a P/E ratio of 25.34.

COPYRIGHT VIOLATION WARNING: “Zacks: Consort Medical plc (CSRMY) Given Consensus Recommendation of “Strong Buy” by Analysts” was published by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Get a free copy of the Zacks research report on Consort Medical plc (CSRMY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with's FREE daily email newsletter.